pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

7,990 catalysts · 4,876 phase readout · 2,350 8k filing · 286 earnings · 275 pdufa · 166 phase 2 completion · 71 phase 1 completion

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-20: 0 catalysts2026-07-21: 0 catalysts2026-07-22: 0 catalysts2026-07-23: 0 catalysts2026-07-24: 12 catalysts2026-07-25: 0 catalysts2026-07-26: 0 catalysts2026-07-27: 2 catalysts2026-07-28: 4 catalysts2026-07-29: 12 catalysts2026-07-30: 12 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type
  • phase readout4,876
  • 8k filing2,350
  • earnings286
  • pdufa275
  • phase 2 completion166
  • phase 1 completion71
  • phase 2 initiation54
  • phase 1 initiation39
  • phase 1 2 completion33
  • phase 0 trial completion23
  • therapy area
    • Oncology139
    • Infectious Disease41
    • Cardiology37
    • Immunology32
    • Dermatology27
    • Pulmonology19
    • Women's Health16
    • Ophthalmology15
    • Pain12

    Week of Apr 27, 2026

    50
    ›Apr 30, 2026phase 2 completion86d agoNational Cheng-Kung University Hospital — SynPro-15G (Phase II Trial Completion)SynPro-15G

    Therapy area: Gastrointestinal. Indication: Irritable Bowel Syndrome

    full page →SynPro-15G →source: globaldata
    ›Apr 30, 2026phase 2 completion86d agoPolice General Hospital — acetaminophen (Phase II Trial Completion)acetaminophen ER

    Therapy area: Central Nervous System, Women's Health. Indication: Labor And Delivery, Pain

    full page →acetaminophen ER →source: globaldata
    ›Apr 30, 2026phase 2 completion86d agoEmory University — (carbidopa + levodopa) (Phase II Trial Completion)(carbidopa + levodopa)

    Therapy area: Central Nervous System. Indication: Cognitive Disorders, Depression

    full page →(carbidopa + levodopa) →source: globaldata
    ›Apr 30, 20268k filing86d ago$HCWB — HCW Biologics Inc. (HCWB) — 8-K filing

    Items: 8.01, 9.01

    full page →edgar 8k ↗
    ›Apr 30, 20268k filing86d ago$BCYC — BICYCLE THERAPEUTICS PLC (BCYC) — 8-K filing

    Items: 2.02, 9.01

    full page →edgar 8k ↗
    ›Apr 30, 20268k filing86d ago$RNAC — Cartesian Therapeutics, Inc. (RNAC) — 8-K filing

    Items: 2.02, 9.01

    full page →edgar 8k ↗
    ›Apr 30, 20268k filing86d ago$QURE — uniQure N.V. (QURE) — 8-K filing

    Items: 7.01, 9.01

    full page →edgar 8k ↗
    ›Apr 30, 20268k filing86d ago$KYMR — Kymera Therapeutics, Inc. (KYMR) — 8-K filing

    Items: 2.02, 9.01

    full page →edgar 8k ↗
    ›Apr 30, 20268k filing86d ago$LLY — ELI LILLY & Co (LLY) — 8-K filing

    Items: 2.02, 9.01

    full page →edgar 8k ↗
    ›Apr 30, 20268k filing86d ago$NVCR — NovoCure Ltd (NVCR) — 8-K filing

    Items: 2.02, 9.01

    full page →edgar 8k ↗
    ›Apr 30, 20268k filing86d agoBRISTOL MYERS SQUIBB CO (BMY, CELG-RI) — 8-K filing

    Items: 2.02, 7.01, 9.01

    full page →edgar 8k ↗
    ›Apr 30, 20268k filing86d ago$PYXS — Pyxis Oncology, Inc. (PYXS) — 8-K filing

    Items: 5.02

    full page →edgar 8k ↗
    ›Apr 30, 20268k filing86d ago$PHAT — Phathom Pharmaceuticals, Inc. (PHAT) — 8-K filing

    Items: 2.02, 9.01

    full page →edgar 8k ↗
    ›Apr 30, 20268k filing86d ago$INDV — Indivior Pharmaceuticals, Inc. (INDV) — 8-K filing

    Items: 2.02, 7.01, 9.01

    full page →edgar 8k ↗
    ›Apr 30, 20268k filing86d ago$BAX — BAXTER INTERNATIONAL INC (BAX) — 8-K filing

    Items: 2.02, 8.01, 9.01

    full page →edgar 8k ↗
    ›Apr 30, 20268k filing86d ago$MRK — Merck & Co., Inc. (MRK) — 8-K filing

    Items: 2.02, 9.01

    full page →edgar 8k ↗
    ›Apr 30, 20268k filing86d ago$INFU — InfuSystem Holdings, Inc (INFU) — 8-K filing

    Items: 7.01

    full page →edgar 8k ↗
    ›Apr 30, 20268k filing86d ago$LXEO — Lexeo Therapeutics, Inc. (LXEO) — 8-K filing

    Items: 5.02

    full page →edgar 8k ↗
    ›Apr 30, 20268k filing86d ago$ALNY — ALNYLAM PHARMACEUTICALS, INC. (ALNY) — 8-K filing

    Items: 2.02, 9.01

    full page →edgar 8k ↗
    ›Apr 30, 20268k filing86d ago$GNPX — Genprex, Inc. (GNPX) — 8-K filing

    Items: 8.01, 9.01

    full page →edgar 8k ↗
    ›Apr 30, 20268k filing86d ago$APTOF — Aptose Biosciences Inc. (APTOF) — 8-K filing

    Items: 7.01, 9.01

    full page →edgar 8k ↗
    ›Apr 30, 20268k filing86d ago$EBS — Emergent BioSolutions Inc. (EBS) — 8-K filing

    Items: 5.07, 9.01

    full page →edgar 8k ↗
    ›Apr 30, 20268k filing86d ago$HALO — HALOZYME THERAPEUTICS, INC. (HALO) — 8-K filing

    Items: 5.02, 9.01

    full page →edgar 8k ↗
    ›Apr 30, 20268k filing86d ago$OGN — Organon & Co. (OGN) — 8-K filing

    Items: 2.02, 9.01

    full page →edgar 8k ↗
    ›Apr 30, 20268k filing86d ago$BRNS — Barinthus Biotherapeutics plc. (BRNS) — 8-K filing

    Items: 2.02, 9.01

    full page →edgar 8k ↗
    ›Apr 30, 20268k filing86d ago$TELO — Telomir Pharmaceuticals, Inc. (TELO) — 8-K filing

    Items: 8.01

    full page →edgar 8k ↗
    ›Apr 30, 20268k filing86d ago$CVKD — Cadrenal Therapeutics, Inc. (CVKD) — 8-K filing

    Items: 7.01, 8.01, 9.01

    full page →edgar 8k ↗
    ›Apr 30, 20268k filing86d ago$NMTC — NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) — 8-K filing

    Items: 5.02, 9.01

    full page →edgar 8k ↗
    ›Apr 30, 20268k filing86d ago$MBOT — Microbot Medical Inc. (MBOT) — 8-K filing

    Items: 7.01, 9.01

    full page →edgar 8k ↗
    ›Apr 30, 20268k filing86d ago$GCTK — Glucotrack, Inc. (GCTK) — 8-K filing

    Items: 7.01, 9.01

    full page →edgar 8k ↗
    ›Apr 30, 20268k filing86d agoOSR Holdings, Inc. (OSRH, OSRHW) — 8-K filing

    Items: 1.01, 7.01, 9.01

    full page →edgar 8k ↗
    ›Apr 30, 20268k filing86d ago$IRTC — iRhythm Holdings, Inc. (IRTC) — 8-K filing

    Items: 2.02, 9.01

    full page →edgar 8k ↗
    ›Apr 30, 20268k filing86d ago$PDEX — PRO DEX INC (PDEX) — 8-K filing

    Items: 2.02, 9.01

    full page →edgar 8k ↗
    ›Apr 30, 20268k filing86d agoRESMED INC (RMD, RSMDF) — 8-K filing

    Items: 2.02, 8.01, 9.01

    full page →edgar 8k ↗
    ›Apr 30, 20268k filing86d ago$CORT — CORCEPT THERAPEUTICS INC (CORT) — 8-K filing

    Items: 2.02, 7.01, 9.01

    full page →edgar 8k ↗
    ›Apr 30, 20268k filing86d ago$SNDX — Syndax Pharmaceuticals Inc (SNDX) — 8-K filing

    Items: 2.02, 9.01

    full page →edgar 8k ↗
    ›Apr 30, 20268k filing86d ago$PAHC — PHIBRO ANIMAL HEALTH CORP (PAHC) — 8-K filing

    Items: 1.01, 2.03, 9.01

    full page →edgar 8k ↗
    ›Apr 30, 20268k filing86d ago$HCWB — HCW Biologics Inc. (HCWB) — 8-K filing

    Items: 8.01, 9.01

    full page →edgar 8k ↗
    ›Apr 30, 20268k filing86d ago$RXRX — RECURSION PHARMACEUTICALS, INC. (RXRX) — 8-K filing

    Items: 5.02, 7.01, 9.01

    full page →edgar 8k ↗
    ›Apr 30, 20268k filing86d ago$SYK — STRYKER CORP (SYK) — 8-K filing

    Items: 2.02, 9.01

    full page →edgar 8k ↗
    ›Apr 30, 20268k filing86d ago$NXTS — Nexentis Technologies Inc. (NXTS) — 8-K filing

    Items: 5.07

    full page →edgar 8k ↗
    ›Apr 30, 20268k filing86d ago$CYDY — CytoDyn Inc. (CYDY) — 8-K filing

    Items: 7.01, 9.01

    full page →edgar 8k ↗
    ›Apr 30, 20268k filing86d ago$EVFM — Evofem Biosciences, Inc. (EVFM) — 8-K filing

    Items: 1.01, 7.01, 9.01

    full page →edgar 8k ↗
    ›Apr 30, 20268k filing86d ago$CERS — CERUS CORP (CERS) — 8-K filing

    Items: 2.02, 9.01

    full page →edgar 8k ↗
    ›Apr 30, 20268k filing86d agoLIGAND PHARMACEUTICALS INC (LGND, LGNDZ, LGNXZ, LGNYZ, LGNZZ) — 8-K filing

    Items: 1.02

    full page →edgar 8k ↗
    ›Apr 30, 20268k filing86d ago$SMMT — Summit Therapeutics Inc. (SMMT) — 8-K filing

    Items: 2.02, 9.01

    full page →edgar 8k ↗
    ›Apr 30, 20268k filing86d ago$MMSI — MERIT MEDICAL SYSTEMS INC (MMSI) — 8-K filing

    Items: 2.02, 7.01, 9.01

    full page →edgar 8k ↗
    ›Apr 30, 20268k filing86d ago$ORKA — Oruka Therapeutics, Inc. (ORKA) — 8-K filing

    Items: 2.02, 8.01, 9.01

    full page →edgar 8k ↗
    ›Apr 30, 20268k filing86d ago$DXCM — DEXCOM INC (DXCM) — 8-K filing

    Items: 2.02, 9.01

    full page →edgar 8k ↗
    ›Apr 30, 20268k filing86d ago$OSTX — OS Therapies Inc (OSTX) — 8-K filing

    Items: 7.01, 9.01

    full page →edgar 8k ↗
    ← prev
    page 13 of 160
    next →